- The United States has lost its measles elimination status after domestic transmission continued for over a year, ending a designation held since 2000. The determination was made by the Pan American Health Organization’s independent verification commission, based partly on CDC evidence.
- As of November 12, the CDC recorded 5,412 measles cases and 591 hospitalizations in 2026—the highest annual case count since 1991. Death totals differ between CDC and state reports.
- A prolonged outbreak in Utah that began in June 2025 was central to the assessment. Kindergarten vaccination coverage has fallen to 92.4%, below the 95% threshold needed to prevent sustained spread.
PAHO Commission Revokes Elimination Status
The United States has lost its measles elimination status after health experts determined that domestic transmission had continued for more than a year, ending a designation held since 2000. The determination belongs to the Pan American Health Organization’s independent verification commission, based partly on CDC evidence—not to the CDC alone. PAHO notified the administration on November 13, and a formal public announcement was expected Tuesday. Elimination never meant zero imported cases; it meant that sustained domestic transmission had been interrupted. Losing the designation marks a substantive change in disease control.
As of November 12, the CDC had recorded 5,412 cases in 2026 and 591 hospitalizations—the highest annual case count since 1991. Death totals differ: the CDC’s 2026 count listed six, while state reports totaled ten. Epidemiologist Katrine Wallace attributes the discrepancy to different reporting methods and definitions. A prolonged Utah outbreak, beginning in June 2025, was central to the assessment, and PAHO has urged the United States to intensify vaccination efforts.
Vaccination Gaps and Policy Dispute
The policy debate centers on vaccine confidence, school vaccination requirements, immunization funding and federal outbreak leadership. Kindergarten vaccination coverage fell to 92.4% in the 2025–26 school year, below the approximately 95% two-dose coverage recommended to prevent sustained measles spread; some communities have substantially lower coverage.
Administration officials attribute the resurgence to vaccination gaps that began during the COVID-19 pandemic and say federal leaders have encouraged vaccination and supported state responses. HHS told KFF Health News it provided approximately $100 million in additional outbreak-response funding. Public-health experts argue that contradictory vaccine messaging, cuts to immunization programs and pressure to loosen school mandates have compounded those earlier gaps. CDC Director Erica Schwartz told Reuters (NASDAQ:TRI) that losing elimination status would not change the agency’s response.
Economic and Public Health Toll
The clearest economic effects are healthcare spending, public-health response costs, and missed work and school—not a demonstrated national market shock. KFF Health News reports that Johns Hopkins researchers estimated roughly $125 million in medical care, outbreak response and productivity losses from U.S. outbreaks over the past two years. Hospitals and local health departments face additional demands for isolation, testing, contact tracing and vaccination outreach. Families bear disruption from illness and missed school or work. Two MMR doses already prevent approximately 97% of infections, so the priority is rebuilding routine immunization and surveillance rather than developing a new vaccine.
The greatest consequences fall on infants too young for routine vaccination, people with weakened immune systems, and communities with low vaccine coverage. Vaccinated people retain strong protection; the status change does not mean the vaccine has stopped working. Rather, it indicates that population-level gaps have become large enough to sustain transmission. Measles can cause pneumonia, serious neurological complications and death. Wallace reports that approximately one in six infected children under five has been hospitalized in the current year’s data. Former CDC deputy director Anne Schuchat described the loss as “a very sad moment,” emphasizing preventable suffering.
Broader Setback and Path to Recovery
Internationally, this is a regional disease-control issue as well as a U.S. one. Travel can introduce infections that then spread through under-vaccinated communities. Emory vaccine expert Walter Orenstein told Reuters that restoring U.S. support for global immunization efforts is important, particularly following disruption associated with U.S. withdrawal from the WHO. Canada lost its elimination status in 2025, while the United Kingdom and several other European countries lost theirs in 2026. The U.S. development is part of a wider setback in measles control.
In the short term, experts expect the priority to remain ending active transmission in affected communities. Reuters identified continuing outbreaks in Pennsylvania, New York and Wisconsin; Brown University epidemiologist Jennifer Nuzzo cautioned that reported cases likely miss some infections. Regaining elimination status requires evidence that sustained transmission has stopped for at least 12 months, supported by high-quality surveillance. Experts identify three linked requirements: higher vaccination uptake across communities, rapid identification and containment of cases, and reliable laboratory and epidemiological monitoring. Former CDC microbiologist Paul Rota told KFF Health News that, with outbreaks expanding in several states, recovery of the designation was not on the immediate horizon. The longer-term risk is a cycle in which persistent immunity gaps allow imported infections to seed new outbreaks, increasing preventable illness and recurring response costs.